IRIS Accounts Production v25.2.0.378 08358524 director 1.2.24 31.1.25 31.1.25 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh083585242024-01-31083585242025-01-31083585242024-02-012025-01-31083585242023-01-31083585242023-02-012024-01-31083585242024-01-3108358524ns15:EnglandWales2024-02-012025-01-3108358524ns14:PoundSterling2024-02-012025-01-3108358524ns10:Director12024-02-012025-01-3108358524ns10:PrivateLimitedCompanyLtd2024-02-012025-01-3108358524ns10:Micro-entities2024-02-012025-01-3108358524ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-3108358524ns10:FullAccounts2024-02-012025-01-3108358524ns5:CurrentFinancialInstruments2025-01-3108358524ns5:CurrentFinancialInstruments2024-01-3108358524ns5:Non-currentFinancialInstruments2025-01-3108358524ns5:Non-currentFinancialInstruments2024-01-3108358524ns10:RegisteredOffice2024-02-012025-01-3108358524ns10:Director112024-01-3108358524ns10:Director112023-01-3108358524ns10:Director112024-02-012025-01-3108358524ns10:Director112023-02-012024-01-3108358524ns10:Director112025-01-3108358524ns10:Director112024-01-31
REGISTERED NUMBER: 08358524 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2025

for

Endopath Ltd

Endopath Ltd (Registered number: 08358524)






Contents of the Financial Statements
for the Year Ended 31 January 2025




Page

Balance Sheet 1


Endopath Ltd (Registered number: 08358524)

Balance Sheet
31 January 2025

31.1.25 31.1.24
£    £    £    £   
FIXED ASSETS 18,816 24,783

CURRENT ASSETS 125,610 150,695

CREDITORS
Amounts falling due within one year (46,789 ) (59,103 )
NET CURRENT ASSETS 78,821 91,592
TOTAL ASSETS LESS CURRENT
LIABILITIES

97,637

116,375

CREDITORS
Amounts falling due after more than one
year

(26,997

)

(36,586

)
NET ASSETS 70,640 79,789

CAPITAL AND RESERVES 70,640 79,789

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Endopath Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08358524

Registered office: 34 Antonine Gate
St. Albans
Hertfordshire
AL3 4JB

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2024 - 2 ) .

Endopath Ltd (Registered number: 08358524)

Balance Sheet - continued
31 January 2025

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2025 and 31 January 2024:

31.1.25 31.1.24
£    £   
H Abdellatif
Balance outstanding at start of year 127,015 123,172
Amounts advanced 91,157 130,721
Amounts repaid (105,047 ) (126,878 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 113,125 127,015

Interest is charged on balance over £10,000 at the HMRC approved rate 2.25% (2023/24: 2.25%).



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 30 October 2025 and were signed by:





H Abdellatif - Director